R0

ALS Immune Signals Depend on Where You Look
T-cell measurements in blood and cerebrospinal fluid showed different associations with ALS progression. The study offers a more precise way to investigate immune biology, but does not establish a clinical test, treatment or viral cause.

Enhertu Stumbles in Early Breast Cancer

A Brain Fungus Is Rising

Roche’s Nearly $2B Atavistik Bet Goes After Cardiometabolic Targets Other Drugs Struggle to Reach

FDA Told a Promising ADC: Not Yet.

Novo’s €1.165B Bet Targets the Burden of Weekly Injections

Erectile Dysfunction Is Already a Cardiovascular Risk Marker. New Data Link It to Glaucoma Too

Retatrutide Isn’t Approved. Online, ‘Reta’ Is Already a Weight-Loss Brand

Novo’s $1.4B Orbis Deal Bets on a New Route to Oral Cardiometabolic Drugs

The next medical AI dataset could come from donated bodies. Consent may be the harder problem
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
